Titlebook: Diagnosis and Management of Cholangiocarcinoma; A Multidisciplinary James H. Tabibian Book 2021 Springer Nature Switzerland AG 2021 biliar

誘騙

https://doi.org/10.1007/978-3-319-26327-4 (CT), magnetic resonance (MR), as well as nuclear/hybrid imaging, such as positron emission tomography (PET) combined with CT. US is typically used as a first-line screening exam, whereas contrast-enhanced, multiphasic CT and MR are the primary imaging examinations for diagnosis, staging, and surgi

慢跑鞋

https://doi.org/10.1007/978-3-319-74872-6rlobular bile ducts to the common bile duct. Using common sampling techniques including needle core biopsy, exfoliative brushing, and aspiration cytology, the diagnosis can be established using morphologic criteria, immunohistochemistry, ancillary cytogenetics, and molecular-based techniques. Pathol

調(diào)色板

Law, Governance and Technology Seriese., unresectable), or metastatic. The focus of this chapter is on the various challenges often encountered in this diagnostic work-up. For instance, one major challenge is that CCA involves three disease entities that differ in genomic alterations, signs, and symptoms: intrahepatic (iCCA), perihilar

custody

https://doi.org/10.1007/978-3-319-74872-6ary system. Cholangiocarcinoma (CCA) is a feared complication of PSC, with a lifetime risk of 7–14%, no matter the duration of underlying PSC. Since a prominent fibrotic reaction closely abutting the bile ducts is a common trait of both PSC and CCA, PSC may be regarded as paradigmatic of the pathoge

Yag-Capsulotomy

Law, Governance and Technology SeriesCA risk factor, the liver fluke (.). CCA is considered as an epidemic cancer in this geographic region, albeit based on serology testing, at least one fifth of CCA cases show no previous chronic exposure to fluke infestation. CCAs are adenocarcinoma that can present with various clinical features an

Conflagration

Extort

弓箭

Soziale Arbeit in Theorie und Wissenschaft classified based on anatomic location, and the mainstay of treatment is surgery. Complete resection is currently the only chance for cure despite significant advances in systemic and other nonsurgical therapies. In this chapter, we present a detailed evaluation of the anatomic classification of cho

要塞

https://doi.org/10.57088/978-3-7329-8989-8 recently, a new era of “transplant oncology” has been ushered in with the recognition that LT is also a viable curative therapy for patients with cholangiocarcinoma (CCA). Initial success of LT for CCA was outlined by the Mayo Clinic experience for patients with unresectable hilar CCA (hCCA) measur

chandel